Sublingual Misoprostol versus Manual Vacuum Aspiration in the Management of Incomplete Miscarriage at Katsina; a Multicentre Randomized Controlled Trial
Not Applicable
Not yet recruiting
- Conditions
- Miscarriage
- Registration Number
- PACTR202310863957659
- Lead Sponsor
- Self
- Brief Summary
Not available
- Detailed Description
Not available
Recruitment & Eligibility
- Status
- Pending
- Sex
- Female
- Target Recruitment
- 170
Inclusion Criteria
Consenting pregnant women who present with incomplete first trimester miscarriage who are haemodynamically stable
Exclusion Criteria
1.Women in shock
2.Patients with allergy to prostaglandins
3.Those with evidence of genital tract infection
4.Patients with background cardiovascular disease, sickle cell disease or bleeding disorder, liver or renal disease
Study & Design
- Study Type
- Interventional
- Study Design
- Not specified
- Primary Outcome Measures
Name Time Method
- Secondary Outcome Measures
Name Time Method
Related Research Topics
Explore scientific publications, clinical data analysis, treatment approaches, and expert-compiled information related to the mechanisms and outcomes of this trial. Click any topic for comprehensive research insights.
What is the mechanism of action of sublingual misoprostol in managing incomplete miscarriage compared to manual vacuum aspiration?
How does sublingual misoprostol compare to standard-of-care manual vacuum aspiration in terms of efficacy and safety for incomplete miscarriage management?
Are there specific biomarkers that can predict patient response to sublingual misoprostol versus manual vacuum aspiration in incomplete miscarriage cases?
What are the known adverse events associated with sublingual misoprostol and how do they compare to those of manual vacuum aspiration in treating incomplete miscarriage?
What are the potential combination therapies or alternative drugs to misoprostol for managing incomplete miscarriage, and how do they compare to manual vacuum aspiration?